诺华-话题@MedSci

#诺华#

235篇内容 | 5219人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1282613, encodeId=ba711282613cc, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华称其日本子公司雇员违反尼洛替尼临床研究方案, objectType=article, longId=29662, objectId=90a4296626f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90a4296626f, replyNumber=0, likeNumber=67, createdTime=2014-01-22, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90a4296626f, moduleTitle=诺华称其日本子公司雇员违反尼洛替尼临床研究方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90a4296626f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282612, encodeId=8be01282612bb, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华骨髓瘤药物LBH589 III期试验达主要目标, objectType=article, longId=27831, objectId=ff232e831d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff232e831d6, replyNumber=0, likeNumber=82, createdTime=2013-12-12, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff232e831d6, moduleTitle=诺华骨髓瘤药物LBH589 III期试验达主要目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff232e831d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282611, encodeId=4d1d12826114f, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华H7N9流感疫苗I期临床取得积极数据, objectType=article, longId=26816, objectId=ab08268161c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab08268161c, replyNumber=0, likeNumber=77, createdTime=2013-11-22, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab08268161c, moduleTitle=诺华H7N9流感疫苗I期临床取得积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab08268161c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282610, encodeId=9b6e128261026, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=瑞士诺华公司为操纵高血压药物“代文”实验数据道歉, objectType=article, longId=25447, objectId=ff682544ec4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff682544ec4, replyNumber=0, likeNumber=65, createdTime=2013-10-17, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff682544ec4, moduleTitle=瑞士诺华公司为操纵高血压药物“代文”实验数据道歉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff682544ec4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282609, encodeId=4fef12826095c, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华眼科药物Jetrea获加拿大卫生部批准, objectType=article, longId=23238, objectId=2582232380d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2582232380d, replyNumber=0, likeNumber=95, createdTime=2013-08-23, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2582232380d, moduleTitle=诺华眼科药物Jetrea获加拿大卫生部批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2582232380d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282608, encodeId=2bc412826088b, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华乙脑疫苗Bexsero获澳大利亚批准, objectType=article, longId=23131, objectId=0da523131a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0da523131a8, replyNumber=0, likeNumber=81, createdTime=2013-08-21, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0da523131a8, moduleTitle=诺华乙脑疫苗Bexsero获澳大利亚批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0da523131a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282607, encodeId=bc76128260ebe, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华依维莫司（afinitor）III期肝癌试验失败, objectType=article, longId=22807, objectId=1f542280ec3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f542280ec3, replyNumber=0, likeNumber=62, createdTime=2013-08-10, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f542280ec3, moduleTitle=诺华依维莫司（afinitor）III期肝癌试验失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f542280ec3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282606, encodeId=6da0128260665, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=FDA批准诺华脑膜炎疫苗Menveo用于2月大婴儿, objectType=article, longId=22564, objectId=63d52256482, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63d52256482, replyNumber=0, likeNumber=71, createdTime=2013-08-04, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63d52256482, moduleTitle=FDA批准诺华脑膜炎疫苗Menveo用于2月大婴儿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63d52256482)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282605, encodeId=da971282605a2, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华Q2成功背后隐藏dovitinib III期肾癌失败, objectType=article, longId=21859, objectId=541d21859f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=541d21859f6, replyNumber=0, likeNumber=70, createdTime=2013-07-24, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=541d21859f6, moduleTitle=诺华Q2成功背后隐藏dovitinib III期肾癌失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=541d21859f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282604, encodeId=01bf1282604b6, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华旗下Secukinumab在银屑病临床研究中胜过依那西普, objectType=article, longId=21183, objectId=6dd7211832f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dd7211832f, replyNumber=0, likeNumber=60, createdTime=2013-07-13, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dd7211832f, moduleTitle=诺华旗下Secukinumab在银屑病临床研究中胜过依那西普, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dd7211832f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282603, encodeId=67a7128260374, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=FDA批准诺华旗下Ilaris用于治疗儿童关节炎, objectType=article, longId=18702, objectId=236418e0263, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=236418e0263, replyNumber=0, likeNumber=75, createdTime=2013-05-16, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=236418e0263, moduleTitle=FDA批准诺华旗下Ilaris用于治疗儿童关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=236418e0263)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282602, encodeId=7e091282602fb, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华药物Afinitor治疗乳腺癌疗效较好, objectType=article, longId=8192, objectId=4a0281923d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a0281923d, replyNumber=0, likeNumber=62, createdTime=2012-07-26, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a0281923d, moduleTitle=诺华药物Afinitor治疗乳腺癌疗效较好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a0281923d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282601, encodeId=9e5f12826015f, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华COPD药物QVA149 首批3项III期研究达主要目标, objectType=article, longId=5412, objectId=12db541285, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12db541285, replyNumber=0, likeNumber=58, createdTime=2012-04-18, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12db541285, moduleTitle=诺华COPD药物QVA149 首批3项III期研究达主要目标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12db541285)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282600, encodeId=ca461282600f3, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=EMA称诺华降压药阿利吉仑存在中风或肾脏疾病的风险, objectType=article, longId=4148, objectId=770f41487c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=770f41487c, replyNumber=0, likeNumber=65, createdTime=2012-02-28, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=770f41487c, moduleTitle=EMA称诺华降压药阿利吉仑存在中风或肾脏疾病的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=770f41487c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1282599, encodeId=f0ac128259923, content=<a href='/topic/show?id=2df29190553' target=_blank style='color:#2F92EE;'>#诺华#</a>, objectTitle=诺华维格列汀（佳维乐）在中国上市, objectType=article, longId=4089, objectId=b10640893f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b10640893f, replyNumber=0, likeNumber=101, createdTime=2012-02-19, rootId=0, userName=nian.wang1982, userId=6f63175, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b10640893f, moduleTitle=诺华维格列汀（佳维乐）在中国上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b10640893f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

诺华

2020-05-29发表于威斯康星

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华称其日本子公司雇员违反尼洛替尼临床研究方案

2014-01-22

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华骨髓瘤药物LBH589 III期试验达主要目标

2013-12-12

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华H7N9流感疫苗I期临床取得积极数据

2013-11-22

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

瑞士诺华公司为操纵高血压药物“代文”实验数据道歉

2013-10-17

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华眼科药物Jetrea获加拿大卫生部批准

2013-08-23

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华乙脑疫苗Bexsero获澳大利亚批准

2013-08-21

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华依维莫司（afinitor）III期肝癌试验失败

2013-08-10

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

FDA批准诺华脑膜炎疫苗Menveo用于2月大婴儿

2013-08-04

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华Q2成功背后隐藏dovitinib III期肾癌失败

2013-07-24

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华旗下Secukinumab在银屑病临床研究中胜过依那西普

2013-07-13

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

FDA批准诺华旗下Ilaris用于治疗儿童关节炎

2013-05-16

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华药物Afinitor治疗乳腺癌疗效较好

2012-07-26

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

诺华COPD药物QVA149 首批3项III期研究达主要目标

2012-04-18

一叶知秋 (审核中...)

前往app查看评论内容

#诺华#

EMA称诺华降压药阿利吉仑存在中风或肾脏疾病的风险

2012-02-28

nian.wang1982 (审核中...)

前往app查看评论内容

#诺华#

诺华维格列汀（佳维乐）在中国上市

2012-02-19

科室
- - 订阅+
  - 更多科室
工具
服务